Recurrent Non-small Cell Lung Cancer Completed Phase 1 Trials for Pemetrexed (DB00642)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01723800PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung CancerTreatment